A
51
7
LNC
49
4
ROP
59
2
VTR
50
-4
LYB
58
3
URBN
38
2
EOG
38
-12
HP
44
-2
ZBH
56
6
COP
40
-7
T
59
3
FITB
58
2
DLTR
34
3
PG
50
2
R
63
-7
WHR
59
4
MAC
62
-2
RL
76
3
WAT
59
5
CA
36
8
A
51
7
LNC
49
4
ROP
59
2
VTR
50
-4
LYB
58
3
URBN
38
2
EOG
38
-12
HP
44
-2
ZBH
56
6
COP
40
-7
T
59
3
FITB
58
2
DLTR
34
3
PG
50
2
R
63
-7
WHR
59
4
MAC
62
-2
RL
76
3
WAT
59
5
CA
36
8
Financhill
Back

First Horizon Vs. Spyre Therapeutics Industry Stock Comparison

Sell
40

FHN
First Horizon

Last Price:
15.50
Seasonality Move:
3.34%
Buy
59

SYRE
Spyre Therapeutics

Last Price:
28.46
Seasonality Move:
-2.85%
Sell
40
First Horizon (FHN) is a Sell

Is First Horizon a Buy, Sell or Hold?

  • The current First Horizon [FHN] share price is $15.39. The Score for FHN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • FHN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Spyre Therapeutics (SYRE) is a Buy

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $29.04. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FHN Stock Price Chart

What is First Horizon's stock price today?

  • The First Horizon share price today is $15.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FHN is experiencing slight buying pressure.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $29.04
    The current trend is moderately bearish and SYRE is experiencing slight buying pressure.

FHN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 43.95 Sell
Chaikin Money Flow: 981763 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.45 - 16.29) Sell
Bollinger Bands (100): (15.05 - 16.35) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.41 Buy
Relative Strength Index (14 RSI): 53.02 Buy
Chaikin Money Flow: 71063 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.98 - 29.52) Buy
Bollinger Bands (100): (25.44 - 33.84) Sell

FHN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.66 Sell
20-day SMA: 15.76 Sell
50-day SMA: 15.85 Sell
200-day SMA: 15.05 Buy
8-day EMA: 15.55 Sell
20-day EMA: 15.69 Sell
50-day EMA: 15.74 Sell
200-day EMA: 15.19 Buy

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.1 Sell
20-day SMA: 28.66 Buy
50-day SMA: 27.88 Buy
200-day SMA: 29.31 Sell
8-day EMA: 28.88 Buy
20-day EMA: 28.56 Buy
50-day EMA: 28.37 Buy
200-day EMA: 27.36 Buy

First Horizon Earnings Growth & FHN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.03 per share, and an increase next year of $0.12 per share.

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.

First Horizon Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):